| Authors: |
Ketch PW; The University of Alabama at Birmingham, School of Medicine, Birmingham, AL., Scalise CB; Natera, Inc, Austin, TX., Recio F; AdventHealth Cancer Institute, Orlando, FL., Berman T; Inova Schar Cancer Institute, Fairfax, VA., Hook N; Natera, Inc, Austin, TX., Loar P; Texas Oncology, Austin, TX., Arend R; The University of Alabama at Birmingham, School of Medicine, Birmingham, AL., Dutta P; Natera, Inc, Austin, TX., Gentry ZL; The University of Alabama at Birmingham, School of Medicine, Birmingham, AL., Kalashnikova E; Natera, Inc, Austin, TX., Malhotra M; Natera, Inc, Austin, TX., Liu MC; Natera, Inc, Austin, TX., Vaccarello L; Zangmeister Cancer Center, Columbus, OH., ElNaggar AC; Natera, Inc, Austin, TX., Holloway R; AdventHealth Cancer Institute, Orlando, FL., Toboni MD; The University of Alabama at Birmingham, School of Medicine, Birmingham, AL. |
